Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules
Authors:
- G.P AdamsGAG.P Adams
- C.C ShallerCSC.C Shaller
- L.L ChappellLCL.L Chappell
- C WuCWC Wu
- E.M HorakEHE.M Horak
- H.H SimmonsHSH.H Simmons
- S LitwinSLS Litwin
- J.D MarksJMJ.D Marks
- L.M WeinerLWL.M Weiner
- M.W BrechbielMBM.W Brechbiel
- 1 May 2000
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 27 (4) , 339-346
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Monoclonal Antibodies in Cancer TreatmentBioDrugs, 1999
- Radioimmunotherapy with alpha-emitting nuclidesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neuBritish Journal of Cancer, 1998
- Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle EmitterNuclear Medicine and Biology, 1998
- Alpha-Emitters for Medical Therapy: Workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996Radiation Research, 1997
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude miceCancer, 1992
- Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.Proceedings of the National Academy of Sciences, 1988
- Radioimmunotherapy with Alpha-Particle-Emitting ImmunoconjugatesScience, 1988
- Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ionsAnalytical Biochemistry, 1984